Live Breaking News & Updates on Subretinal Delivery

Stay updated with breaking news from Subretinal delivery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

REGENXBIO Announces Upcoming Presentations at the American Society of Retina Specialists Annual Scientific Meeting

ROCKVILLE - REGENXBIO Inc. today announced three presentations at the American Society of Retina Specialists Annual Scientific Meeting, taking place in Seattle, Washington from July 28 through. ....

United States , Ashkanm Abbey , Davids Boyer , Dilshers Dhoot , Chris Brinzey , American Society , Clinical Research , Ut Southwestern Medical Center , Technology Platform Licensees , Texas Retina Associates , Vitreous Associates Medical Group , Technology Platform , Subretinal Delivery , Retina Associates , Clinical Assistant Professor , Suprachoroidal Delivery , Senior Partner , Diabetic Retinopathy , Platform Licensees , News Publishing ,

REGENXBIO Announces Upcoming Presentations at the American Society of Retina Specialists Annual Scientific Meeting

/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced three presentations at the American Society of Retina Specialists (ASRS) Annual Scientific. ....

United States , Davids Boyer , Dilshers Dhoot , Chris Brinzey , Ashkanm Abbey , Clinical Research At Texas Retina Associates , Vitreous Associates Medical Group , Technology Platform , American Society Of Retina Specialists , Ut Southwestern Medical Center , Technology Platform Licensees , American Society , Retina Specialists , Annual Scientific Meeting , Subretinal Delivery , Clinical Research , Texas Retina Associates , Clinical Assistant Professor , Sunday July , Suprachoroidal Delivery , Senior Partner , Retina Vitreous Associates Medical Group , Diabetic Retinopathy , California Retinal , Tuesday August , Platform Licensees ,

REGENXBIO Announces Presentations at the Angiogenesis, Exudation, and Degeneration 2023 Conference

/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced that three presentations on RGX-314 will be presented at the Angiogenesis, Exudation, and. ....

United States , Petera Campochiaro , Dana Cormack , Charlesc Wykoff , Chris Brinzey , John Hopkins School Of Medicine , Molecular Laboratory , Technology Platform , Corporate Communications , Technology Platform Licensees , Retina Research , Subretinal Delivery , Retina Consultants , Long Term Follow Up , Durable Subretinal , Wills Eye Hospital , Mid Atlantic , Suprachoroidal Therapy , Retinal Cell , John Hopkins School , Platform Licensees , Regenxbio Inc ,

REGENXBIO Announces RGX-314 Data Presentations at American Society of Retina Specialists Annual Meeting

/PRNewswire/ Data for Cohort 1 with three months of follow-up from the RGX-314 Phase II trial for the treatment of diabetic retinopathy (ALTITUDE®) to be. ....

United States , University Of Arizona , San Antonio , David Rosen , Dennis Marcus , Lejla Vajzovic , Brendan Burns , Tricia Truehart , Mark Barakat , Technology Platform , Technology Platform Licensees , American Society Of Retina Specialists Annual Meeting , Clearside Biomedical Inc , Duke Eye Center Continuing Medical Education , Corporate Communications , Southeast Retina Center , University Of Arizona College Medicine , American Society , Retina Specialists Annual Meeting , Suprachoroidal Delivery , Diabetic Retinopathy Without , Early Results From , Southeast Retina , Diabetic Retinopathy , Subretinal Delivery , Study Phase ,

REGENXBIO Announces RGX-314 Data Presentations at Retina Society 54th Annual Scientific Meeting and KOL Conference Call

REGENXBIO Announces RGX-314 Data Presentations at Retina Society 54th Annual Scientific Meeting and KOL Conference Call
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Scripps Memorial Hospital , David Rosen , Peter Campochiaro , Brendan Burns , Tricia Truehart , Molecular Laboratory , Technology Platform , Technology Platform Licensees , Johns Hopkins University School Of Medicine , Clearside Biomedical Inc , Exchange Commission , Wilmer Eye Institute , Retina Research At Wills Eye Hospital , Corporate Communications , Securities Exchange , Retina Society , Opinion Leaders , Nikolas London , Annual Scientific Meeting , Retina Consultants , Retinal Cell , Johns Hopkins University School , Subretinal Delivery , Study Phase ,